Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 3 vs 4 times daily amoxicillin dosing in triple therapy for Helicobacter pylori eradication
IRCT20240507061691N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Feb 2025; status: completed.
02
Drugs
amoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20240507061691N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240507061691N1.